TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10473769

Group type: EXPERIMENTAL
Intervention: Interhemispheric transfer during simple reaction time tasks
Number of subjects: 12
Study: 8730885

Group type: EXPERIMENTAL
Intervention: Histochemical evaluation of placental angiotensinase A activity in pre-eclampsia
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Histochemical evaluation of placental angiotensinase A activity in pregnancy-induced hypertension
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Histochemical evaluation of placental angiotensinase A activity in uncomplicated pregnancies
Number of subjects: 87

Group type: COMPARATOR
Intervention: Biochemical measurements of fetal blood vessels
Number of subjects: 87
Study: 1680996

Group type: EXPERIMENTAL
Intervention: Trichlormethiazide (1 tab qd)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Enalapril (1 tab qd)
Number of subjects: 7
Study: 30063247

Group type: EXPERIMENTAL
Intervention: Misoprostol alone
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Misoprostol and subsequent vacuum aspiration
Number of subjects: 102

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 102
Study: 26758574

Group type: EXPERIMENTAL
Intervention: Saffron (1 g)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Ginger (3 g)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Cinnamon (3 g)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Cardamom (3 g)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Control (3 glasses of tea without herbs)
Number of subjects: 204
Study: 24708509

Group type: EXPERIMENTAL
Intervention: Botsourcing jobs requiring cognition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Botsourcing jobs requiring emotion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Botsourcing jobs requiring emotion with robots conveying more emotion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Outsourcing cognition-oriented jobs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Outsourcing emotion-oriented jobs
Number of subjects: 0
Study: 22613585

Group type: EXPERIMENTAL
Intervention: Cross-linked polyelectrolyte (CLP)
Number of subjects: 111
Study: 20431290

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg daily
Number of subjects: 227

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 227
Study: 18327970

Group type: EXPERIMENTAL
Intervention: Wand local anesthetic system at a deposition rate of 45 seconds (fast injection)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Wand local anesthetic system at a deposition rate of 4 minutes and 45 seconds (slow injection)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Conventional syringe injection at a deposition rate of 4 minutes and 45 seconds (slow injection)
Number of subjects: 61
Study: 15912483

Group type: EXPERIMENTAL
Intervention: Alcohol (average 40 mg and 28 mg alcohol/100 ml blood at the beginning and end of drive)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sleep restriction
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control drink (double blind)
Number of subjects: 8
Study: 12897272

Group type: EXPERIMENTAL
Intervention: Prompt tympanostomy tube insertion
Number of subjects: 429

Group type: COMPARATOR
Intervention: Late tympanostomy tube insertion
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Cumulative durations of MEE
Number of subjects: 429
Study: 10391361

Group type: EXPERIMENTAL
Intervention: Bradycor (3 microg/kg/min)
Number of subjects: 139
Study: 8929262

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 1908498

Group type: EXPERIMENTAL
Intervention: Praziquantel therapeutic course
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Initial full dose of praziquantel followed by suppressive doses
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Initial loading praziquantel dose followed by suppressive dose at monthly intervals
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Oral metrifonate therapeutic course followed by prophylactic course monthly
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Full dose of oral praziquantel
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Metrifonate orally every month
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Half dose of praziquantel orally every month
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Oral metrifonate curative course every 2 weeks for 3 doses every 6 months
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Oral monthly praziquantel prophylactic dose
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Praziquantel prophylactic doses at 3-monthly intervals
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Oral placebo in the form of vitamin B complex tablets at 3-monthly intervals
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Oral monthly therapeutic dose of metrifonate
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Oral monthly prophylactic doses of praziquantel
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Oral placebo in the form of 2 vitamin B-complex tablets monthly
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Praziquantel treatment
Number of subjects: 14
Study: 6684447

Group type: EXPERIMENTAL
Intervention: febuprol (Valbil)
Number of subjects: 712
Study: 30413359

Group type: EXPERIMENTAL
Intervention: Tablet-based interactive distraction (TBID; 1 minute preseparation)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Oral midazolam (15 to 45 minutes of preseparation)
Number of subjects: 102
Study: 28738939

Group type: EXPERIMENTAL
Intervention: Cavity shave margins (CSMs)
Number of subjects: 235

Group type: COMPARATOR
Intervention: No cavity shave margins (CSMs)
Number of subjects: 235
Study: 25853795

Group type: EXPERIMENTAL
Intervention: Self-ligating bracket (3M SmartClip)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Conventional bracket (3M Victory)
Number of subjects: 138
Study: 24647921

Group type: EXPERIMENTAL
Intervention: Varenicline (titrated to 2 mg)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 22922245

Group type: EXPERIMENTAL
Intervention: E-Coach intervention (IVR-enhanced care transition intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 0
Study: 18716800

Group type: EXPERIMENTAL
Intervention: full-mouth disinfection plus essential oils (Listerine)
Number of subjects: 20

Group type: COMPARATOR
Intervention: full-mouth disinfection plus placebo
Number of subjects: 20
Study: 17698729

Group type: EXPERIMENTAL
Intervention: Low-saturated-fat, low-cholesterol dietary counseling
Number of subjects: 1062

Group type: COMPARATOR
Intervention: Unrestricted diet (Control)
Number of subjects: 1062
Study: 16307708

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg
Number of subjects: 461

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20 mg
Number of subjects: 461

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 40 mg
Number of subjects: 461

Group type: COMPARATOR
Intervention: Atorvastatin 20 mg
Number of subjects: 461

Group type: COMPARATOR
Intervention: Atorvastatin 40 mg
Number of subjects: 461

Group type: COMPARATOR
Intervention: Atorvastatin 80 mg
Number of subjects: 461
Study: 12049862

Group type: EXPERIMENTAL
Intervention: Chemoembolisation (gelatin sponge plus doxorubicin)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Embolisation (gelatin sponge)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Conservative treatment (control)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Chemoembolisation
Number of subjects: 112
Study: 9535410

Group type: EXPERIMENTAL
Intervention: Increased dermal glucocorticoid sensitivity
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Enhanced glucocorticoid sensitivity and secretion of cortisol
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Increased tissue sensitivity to cortisol
Number of subjects: 137
Study: 8562040

Group type: EXPERIMENTAL
Intervention: 20 mg EMD 55900
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 100 mg EMD 55900
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 400 mg EMD 55900
Number of subjects: 12
Study: 2708742

Group type: EXPERIMENTAL
Intervention: Nicergoline (daily oral dose, 30 mg, and intravenous dose during dialyses, 5 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Nicergoline (daily dose of 30 mg for 6 months after trial)
Number of subjects: 15
Study: 778987

Group type: EXPERIMENTAL
Intervention: Sulindac (400 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ibuprofen (1200 mg/day)
Number of subjects: 40
Study: 30377243

Group type: EXPERIMENTAL
Intervention: Electric heating
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control (quick‐light charcoal)
Number of subjects: 34
Study: 31196131

Group type: EXPERIMENTAL
Intervention: High pressure group (arterial pressure > 60 mmHg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (mean arterial pressure 47 ± 5 mmHg)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: High pressure group
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study: 27807279

Group type: EXPERIMENTAL
Intervention: Pharyngeal electrical stimulation (PES)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Standard therapy (control)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: PES
Number of subjects: 126
Study: 25073872

Group type: EXPERIMENTAL
Intervention: N-acetyl-cysteine (NAC)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 23124529

Group type: EXPERIMENTAL
Intervention: Exposure group therapy (n = 33)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Virtual reality exposure therapy (n = 32)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Waiting period (control group)
Number of subjects: 65
Study: 21750426

Group type: EXPERIMENTAL
Intervention: Oxycodone (15 mg, orally)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19841125

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (iNO) therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (iNO) therapy (initiated between 7 and 14 days of life)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (initiated between 7 and 14 days of life)
Number of subjects: 100
Study: 16751063

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 100
Study: 15286528

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation program (CRP)
Number of subjects: 65

Group type: COMPARATOR
Intervention: No participation in CRP (Control)
Number of subjects: 65
Study: 11350509

Group type: EXPERIMENTAL
Intervention: Lidocaine/prilocaine gel (Oraqix) applied for 30 seconds
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lidocaine/prilocaine gel (Oraqix) applied for 2 minutes
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lidocaine/prilocaine gel (Oraqix) applied for 5 minutes
Number of subjects: 30
Study: 10036600

Group type: EXPERIMENTAL
Intervention: Desogestrel (150 micrograms)
Number of subjects: 1016

Group type: COMPARATOR
Intervention: Gestodene (75 micrograms)
Number of subjects: 1016

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 1016
Study: 8182837

Group type: EXPERIMENTAL
Intervention: Consumption of one-half to one clove of garlic per day
Number of subjects: 0
Study: 2558186

Group type: EXPERIMENTAL
Intervention: Pyridoxine (vitamin B6) 50 mg per day
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 765457

Group type: EXPERIMENTAL
Intervention: Miconazole nitrate (Monistat Cream 2%) administered once daily at bedtime for 14 days
Number of subjects: 95

Group type: COMPARATOR
Intervention: Nystatin vaginal tablets (100,000 units each) administered twice daily for 15 days
Number of subjects: 95
Study: 29497091

Group type: EXPERIMENTAL
Intervention: Palbociclib and fulvestrant
Number of subjects: 0
Study: 28126581

Group type: EXPERIMENTAL
Intervention: CAMS (Collaborative Assessment and Management of Suicidality) therapy
Number of subjects: 104

Group type: COMPARATOR
Intervention: Usual intensive inpatient treatment (Control)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: CAMS and Control (combined)
Number of subjects: 104
Study: 26025994

Group type: EXPERIMENTAL
Intervention: Levalbuterol 1.25 mg three times daily
Number of subjects: 112

Group type: COMPARATOR
Intervention: Albuterol 2.5 mg four times daily
Number of subjects: 112
Study: 22978252

Group type: EXPERIMENTAL
Intervention: Fixed combination of beclomethasone (BDP) 50μg and formoterol 6μg (Foster® pMDI)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Free combination of BDP 200μg and formoterol 24μg
Number of subjects: 20
Study: 20855350

Group type: EXPERIMENTAL
Intervention: Bilastine 20 mg
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Bilastine 40 mg
Number of subjects: 22

Group type: COMPARATOR
Intervention: Hydroxyzine 50 mg
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 18241919

Group type: EXPERIMENTAL
Intervention: Induction treatment with thalidomide (TAD)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Induction treatment with adriamycin and dexamethasone in combination with vincristin (VAD)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Induction treatment with bortezomib (PAD)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Post-ASCT (after high-dose melphalan and autologous stem cell transplant)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Pre-treatment levels of VWF, fibrinogen and FVIII:C
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Coagulation factor abnormalities before and during treatment
Number of subjects: 138
Study: 16817845

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg once daily
Number of subjects: 224

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 224
Study: 14986871

Group type: EXPERIMENTAL
Intervention: NIDA standard HIV intervention
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Rural-focused HIV intervention
Number of subjects: 200
Study: 10560987

Group type: EXPERIMENTAL
Intervention: Preimplantation genetic diagnosis for aneuploidy
Number of subjects: 262

Group type: COMPARATOR
Intervention: Assisted zona hatching (Control)
Number of subjects: 262
Study: 8880364

Group type: EXPERIMENTAL
Intervention: 1-tone paradigm (target tone only, standard replaced by silence)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2-tone paradigm (target and standard tones presented every 2.0 s, target-tone probability 0.10)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3-tone paradigm (target tone probability 0.10, standard tone probability 0.80, nontarget tone probability 0.10)
Number of subjects: 0
Study: 2127269

Group type: EXPERIMENTAL
Intervention: Cefpodoxime proxetil
Number of subjects: 236
Study: 7361272

Group type: EXPERIMENTAL
Intervention: 3.5% amino acids (essential and nonessential)
Number of subjects: 12

Group type: COMPARATOR
Intervention: 3.5% amino acids with 2.5% glucose
Number of subjects: 12
Study: 31725311

Group type: EXPERIMENTAL
Intervention: Unconditional cash transfer ($300/year)
Number of subjects: 10000

Group type: EXPERIMENTAL
Intervention: Subsidized community-supported agriculture (CSA) ($300/year subsidy)
Number of subjects: 10000
Study: 31437124

Group type: EXPERIMENTAL
Intervention: Aromatherapy (inhalation of essential oil blend)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (odorless vegetable oil blend)
Number of subjects: 0
Study: 28327083

Group type: EXPERIMENTAL
Intervention: Combined cognitive-aerobic bicycle training (interactive cycling)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single aerobic bicycle training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control intervention (stretching and toning exercises)
Number of subjects: 0
Study: 25599314

Group type: EXPERIMENTAL
Intervention: Parent-directed education (pamphlet and video about vaccination pain management)
Number of subjects: 160
Study: 24512193

Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sitagliptin 100 mg
Number of subjects: 0
Study: 21596485

Group type: COMPARATOR
Intervention: 5 Gy within 7 fractions (Group 1)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 2 Gy within 10 fractions (Group 2)
Number of subjects: 200
Study: 21045083

Group type: EXPERIMENTAL
Intervention: Everolimus 10 mg orally daily until disease progression
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Everolimus 10 mg orally daily
Number of subjects: 40
Study: 17351253

Group type: COMPARATOR
Intervention: Cisplatin-gemcitabine (standard arm)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Gemcitabine alone (experimental arm)
Number of subjects: 250
Study: 15661436

Group type: EXPERIMENTAL
Intervention: Neonatal procedural pain exposure (number of skin breaking procedures)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Morphine exposure since birth
Number of subjects: 87
Study: 11873239

Group type: EXPERIMENTAL
Intervention: High-dose intravenous IL-2 therapy
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Low-dose intravenous IL-2 therapy
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Subcutaneous IL-2 therapy
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: All IL-2 therapies
Number of subjects: 28
Study: 10444908

Group type: EXPERIMENTAL
Intervention: Complementary medical services included in the basic cover for 3 years (experimental group)
Number of subjects: 7500

Group type: COMPARATOR
Intervention: Control group (no access to complementary medical services)
Number of subjects: 7500
Study: 7789452

Group type: EXPERIMENTAL
Intervention: Increasing perceived curvature of normally straight sagittal movements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increasing curvature of normally curved transverse movements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reducing curvature of naturally curved transverse movements
Number of subjects: 0
Study: 3292344

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 23

Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 23
Study: 30586726

Group type: EXPERIMENTAL
Intervention: Lorcaserin
Number of subjects: 12000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12000
Study: 29723455

Group type: EXPERIMENTAL
Intervention: TESE (n = 50)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: TESA (n = 56)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: TEFNA (n = 64)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: micro-TESE (n = 40)
Number of subjects: 210
Study: 25654585

Group type: EXPERIMENTAL
Intervention: Colloid osmotic pressure guidance with albumin (ALB)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional fluid protocols without COP support (control)
Number of subjects: 30
Study: 22877571

Group type: EXPERIMENTAL
Intervention: Supermarket vouchers for 4 weeks
Number of subjects: 214

Group type: COMPARATOR
Intervention: Control group (no vouchers)
Number of subjects: 214
Study: 21943782

Group type: EXPERIMENTAL
Intervention: Anakinra combined with MTX
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo plus MTX
Number of subjects: 50
Study: 18436293

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (Lactobacillus casei CRL431 and Bifidobacterium lactis Bb‐12)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo (extensively hydrolyzed formula)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study: 20348032

Group type: EXPERIMENTAL
Intervention: Pharmacist led educational outreach (SOS)
Number of subjects: 4040

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 4040
Study: 16273644

Group type: EXPERIMENTAL
Intervention: Saccharomyces boulardii (Sb) 0.5 g bid PO for 6 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 10
Study: 12018879

Group type: EXPERIMENTAL
Intervention: Stenting
Number of subjects: 92

Group type: COMPARATOR
Intervention: Balloon Angioplasty
Number of subjects: 92
Study: 10434909

Group type: EXPERIMENTAL
Intervention: Standardized ultrasonic technique
Number of subjects: 15

Group type: COMPARATOR
Intervention: Normal non-weightbearing heel pad thickness measurement
Number of subjects: 15
Study: 7913906

Group type: EXPERIMENTAL
Intervention: Intravenous bolus injection of 250 micrograms somatostatin
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Continuous infusion of somatostatin after bolus injection
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 36
Study: 3293417

Group type: EXPERIMENTAL
Intervention: Probucol (500 mg twice daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11759857

Group type: EXPERIMENTAL
Intervention: Envelope technique (E)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Coronally positioned flap combined with connective tissue graft (CP)
Number of subjects: 21
Study: 30733182

Group type: EXPERIMENTAL
Intervention: Participatory community mobilisation (PLA)
Number of subjects: 11454

Group type: EXPERIMENTAL
Intervention: mHealth mobile phone messaging
Number of subjects: 11454

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 11454
Study: 29555492

Group type: EXPERIMENTAL
Intervention: Periarticular local anesthetic infiltration
Number of subjects: 99

Group type: COMPARATOR
Intervention: Psoas compartment block (PCB)
Number of subjects: 99
Study: 27541442

Group type: EXPERIMENTAL
Intervention: Text message reminders and free topical corticosteroid medication
Number of subjects: 209

Group type: COMPARATOR
Intervention: Standard follow-up without reminders or free medication
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Intervention group with suture removal instructions
Number of subjects: 209

Group type: COMPARATOR
Intervention: Control group not told about suture removal
Number of subjects: 209
Study: 24894197

Group type: EXPERIMENTAL
Intervention: Selenium administration
Number of subjects: 5001

Group type: EXPERIMENTAL
Intervention: Vitamin E administration
Number of subjects: 5001

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5001
Study: 22048460

Group type: EXPERIMENTAL
Intervention: Varenicline (1 mg twice daily for weeks 2-8)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 20369762

Group type: EXPERIMENTAL
Intervention: CPAP of 10 cmH2O during bypass
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (no CPAP during bypass)
Number of subjects: 44